Newly FDA-approved drug nogapendekin alfa inbakicept (Anktiva) needs to be updated

[ratardif]

The FDA approved the drug Anktiva (nogapendekin alfa inbakicept) in April 22, 2024. It needs to be added/updated with the new RxNorm IDs for the ingredients and dosage.

I have provided the RxNorm information below:

Ingredient- nogapendekin alfa inbakicept = RxNorm 2682678
Precise Ingredient- Nogapendekin alfa inbakicept-pmln = RxNorm 2682677
Brand Name- Anktiva = RxNorm 2682686
0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Injection = RxNorm 2682684

Please let me know if you need anything else.
Thank you.
Robin

[TinyRickC137]

Thank you, @ratardif

Vocabularies are updated twice a year, therefore, we can't include the latest versions - there will always be a small delay. The concepts are in RxNorm already, therefore, we will add them to the next release.